Inflammatory reactions are involved in the development of steroid-induced osteonecrosis of the femoral head(ONFH). Studies have explored the therapeutic efficacy of inhibiting inflammatory reactions in steroid-induced ONFH and revealed that inhibiting inflammation may be a new strategy for preventing the development of steroid-induced ONFH. Exosomes derived from M2 macrophages(M2-Exos) display anti-inflammatory properties. This study aimed to examine the preventive effect of M2-Exos on early-stage steroid-induced ONFH and explore the underlying mechanisms involved. In vitro, we explored the effect of M2-Exos on the proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells(BMMSCs). In vivo, we investigated the role of M2-Exos on inflammation, osteoclastogenesis, osteogenesis and angiogenesis in an early-stage rat model of steroid-induced ONFH. We found that M2-Exos promoted the proliferation and osteogenic differentiation of BMMSCs. Additionally, M2-Exos effectively attenuated the osteonecrotic changes, inhibited the expression of proinflammatory mediators, promoted osteogenesis and angiogenesis, reduced osteoclastogenesis, and regulated the polarization of M1/M2 macrophages in steroid-induced ONFH. Taken together, our data suggest that M2-Exos are effective at preventing steroid-induced ONFH. These findings may be helpful for providing a potential strategy to prevent the development of steroid-induced ONFH.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020342PMC
http://dx.doi.org/10.1186/s13018-024-04711-1DOI Listing

Publication Analysis

Top Keywords

steroid-induced onfh
28
development steroid-induced
12
steroid-induced
9
exosomes derived
8
steroid-induced osteonecrosis
8
osteonecrosis femoral
8
inflammatory reactions
8
proliferation osteogenic
8
osteogenic differentiation
8
osteogenesis angiogenesis
8

Similar Publications

Background: Glucocorticoids (GCs) are critical regulatory molecules in the body, commonly utilized in clinical practice for their potent anti-inflammatory and immunosuppressive properties. However, prolonged, high-dose GC therapy is frequently associated with femoral head necrosis, a condition known as glucocorticoid-induced osteonecrosis of the femoral head (GC-ONFH). Emerging evidence suggests that enhanced autophagy may mitigate apoptosis, thereby protecting osteoblasts from GC-induced damage and delaying the progression of ONFH.

View Article and Find Full Text PDF

Background: Osteonecrosis of the femoral head (ONFH) is a refractory orthopedic disease with a high disability rate. Long-term administration of steroids is the most common pathogenic factor for non-traumatic ONFH. Early diagnosis of steroid-induced osteonecrosis of the femoral head (SONFH) is difficult and mainly depends on imaging.

View Article and Find Full Text PDF

Methylprednisolone (MPS) use is linked to increased cases of osteonecrosis of the femoral head (ONFH). Bone marrow mesenchymal stem cells (BMSCs) have shown potential for treating MPS-induced ONFH, but their effectiveness is limited by high apoptosis rates post-transplantation. We developed a pre-treatment strategy for BMSCs to improve their viability.

View Article and Find Full Text PDF

Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis of the femoral head by suppressing osteoclast activity through the reduction of cellular oxidative stress.

Chem Biol Interact

December 2024

Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China; Orthopaedic Research Laboratory, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China; Department of Joint Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. Electronic address:

Article Synopsis
  • Osteonecrosis of the femoral head (ONFH) is a severe hip disease linked to oxidative stress from high-dose glucocorticoid use, and protein disulfide isomerase (PDI) is suggested to play a crucial role in regulating oxidative stress in osteoclasts.
  • The study identified 70 potential gene targets for intervention in steroid-induced ONFH, emphasizing PDI's importance through bioinformatics, network analysis, and in vitro experiments with dexamethasone (DEX), which stimulate osteoclast formation.
  • Molecular docking experiments assessed various PDI inhibitors, revealing significant binding energies and interaction mechanisms, suggesting that PDI plays a positive regulatory role in osteoclastogenesis stimulated by dexamethasone
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on how steroid-induced femoral head osteonecrosis (ONFH) is linked to an imbalance in bone homeostasis, particularly through the effects of bone marrow-derived mesenchymal stem cells (BMSCs).
  • Inhibiting monoacylglycerol lipase (MAGL) has shown promise in improving ONFH by reducing oxidative stress and promoting the differentiation of BMSCs towards bone-forming cells instead of fat cells.
  • The research identifies the cannabinoid receptor 2 (CB2) as the key receptor involved in this process and highlights that MAGL inhibition helps maintain bone balance by suppressing bone resorption and influencing pathways related to BMSC differentiation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!